The rise of Sildenafil initially sparked a boom for major pharmaceutical companies, however recent shifts present a complicated outlook for investors. Lower-cost versions are reducing earnings, and persistent legal https://siobhanpbbm926573.life3dblog.com/39640441/viagra-and-the-pharmaceutical-industry-a-volatile-play